MIR3649

Across TCGA pan-cancer cohorts, MIR3649 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR3649’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MIR3649 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3649 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

LIHC, KICH, and PAAD are the cancer types where MIR3649 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3649 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.571	<.001	5	view →
KICH	All	All	+0.396	.003	5	view →
PAAD	Female	All	−1.050	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR3649–LIHC

Open the LIHC breakdown →